Status:
RECRUITING
Vomiting Prevention in Children With Cancer
Lead Sponsor:
The Hospital for Sick Children
Conditions:
Chemotherapy Induced Nausea and Vomiting
Quality of Life (QOL)
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this single arm trial is to learn if a machine learning (ML) model predicting the risk of vomiting within the next 96 hours will impact vomiting outcomes in inpatient cancer pediatric pati...
Detailed Description
Vomiting is one of the most common complications of cancer therapies in pediatric patients, with substantial negative impacts on quality of life. Vomiting can also reduce oral intake, worsen nutrition...
Eligibility Criteria
Inclusion
- All pediatric patients admitted to the oncology service at SickKids
Exclusion
- Pediatric patients admitted to the oncology service at SickKids that are discharged prior to prediction time
Key Trial Info
Start Date :
March 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 18 2027
Estimated Enrollment :
1332 Patients enrolled
Trial Details
Trial ID
NCT06886451
Start Date
March 18 2025
End Date
March 18 2027
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G1X8